The CXC chemokine, monokine induced by interferon-γ, inhibits non-small cell lung carcinoma tumor growth and metastasis

Human Gene Therapy

Volumn 11, Issue 2, 2000, Pages 247-261

  Addison, Christina L ^a   Arenberg, Douglas A ^a   Morris, Susan B ^a   Xue, Ying Ying ^b   Burdick, Marie D ^b   Mulligan, Michael S ^a   Iannettoni, Mark D ^a   Strieter, Robert M ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; MONOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; GENE THERAPY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; LUNG NON SMALL CELL CANCER; METASTASIS INHIBITION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR VASCULARIZATION;

ADENOVIRIDAE; ANIMALS; ANTIGENS, CD31; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIVISION; CHEMOKINES, CXC; GENETIC VECTORS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERFERON TYPE II; LUNG; LUNG NEOPLASMS; MICE; MICE, SCID; MICE, TRANSGENIC; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, INTERLEUKIN-2; RECOMBINATION, GENETIC; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034688120     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340050015996     Document Type: Article

References (45)

1. ADDISON, C.L., HITT, M., KUNSKEN, D., and GRAHAM, F.L. (1997). Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors. J. Gen. Virol. 78, 1653-1661.
2. AMICIIAY, D., GAZZINELLI, R.T., KARUPIAII, G., MOENCII, T.R., SHER, A., and FARBER, J.M. (1996). Genes for chemokines MuMig and Crg-2 are induced in protozoan and viral infections in response to IFN-gamma with patterns of tissue expression that suggest nonredundant roles in vivo. J. Immunol. 157, 4511-4520.
3. ANGIOLILLO, A.L., SGADARI, C., TAUB, D.D., LIAO, F., FARBER, J.M., MAHESHWARI, S., KLEINMAN, H.K., REAMAN, G.H., and TOSATO, G. (1995). Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J. Exp. Med. 182, 155-162.
4. ANGIOLILLO, A.L., SGADARI, C., and TOSATO, G. (1996). A role for the interferon-inducible protein 10 in inhibition of angiogenesis by interleukin-12. Ann. N.Y. Acad. Sci. 795, 158-167.
5. ARENBERG, D.A., KUNKEL, S.L., POLVERINI, P.J., GLASS, M., BURDICK, M.D., and STRIETER, R.M. (1996a). Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J. Clin. Invest. 97, 2792-2802.
6. ARENBERG, D.A., KUNKEL, S.L., POLVERINI, P.J., MORRIS, S.B., BURDICK, M.D., GLASS, M.C., TAUB, D.T., IANNETTONI, M.D., WHYTE, R.I., and STRIETER, R.M. (1996b). Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J. Exp. Med. 184, 981-992.
7. ARENBERG, D.A., KEANE, M.P., DIGIOVINE, B., KUNKEL, S.L., MORRIS, S.B., XUE, Y.Y., BURDICK, M.D., GLASS, M.C., IANNETTONI, M.D., and STRIETER, R.M. (1998). Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer. J. Clin. Invest. 102, 465-472.
8. BARR, D., TUBB, J., FERGUSON, D., SCARIA, A., LIEBER, A., WILSON, C., PERKINS, J., and KAY, M.A. (1995). Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: Comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther. 2, 151-155.
9. BERGERS, G., JAVAHERIAN, K., LO, K.M., FOLKMAN, J., and HANAHAN, D. (1999). Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 284, 808-812.
10. BETT, A.J., HADDARA, W., PREVEC, L., and GRAHAM, F.L. (1994). An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc. Natl. Acad. Sci. U.S.A. 91, 8802-8806.
11. CAO, Y., O'REILLY, M.S., MARSHALL, B., FLYNN, E., JI, R.W., and FOLKMAN, J. (1998). Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases. J. Clin. Invest. 101, 1055-1063.
12. COUGHLIN, C.M., SALHANY, K.E., WYSOCKA, M., ARUGA, E., KURZAWA, H., CHANG, A.E., HUNTER, C.A., FOX, J.C., TRINCHIERI, G., and LEE, W.M.F. (1998). Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J. Clin. Invest. 101, 1441-1452.
13. FAN, X.D., STARK, G.R,, and BLOOM, B.R. (1989). Molecular cloning of a gene selectively induced by gamma interferon from human macrophage cell line U937. Mol. Cell. Biol. 9, 1922-1928.
14. FARBER, J.M. (1993). HuMig: A new human member of the chemokine family of cytokines. Biochem. Biophys. Res. Commun. 192, 223-230.
15. FARBER, J.M. (1997). Mig and IP-10: CXC chemokines that target lymphocytes. J. Leukocyte Biol. 61, 246-257.
16. GRAHAM, F.L., SMILEY, J., RUSSELL, W.C., and NAIRN, R. (1977). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36, 59-74.
17. HARPOLE, D.H., JR., RICHARDS, W.G., HERNDON, J.E., II, and SUGARBAKER, D.J. (1996). Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer. Ann. Thorac. Surg. 61, 1470-1476.
18. HITT, M., BETT, A.J., PREVEC, L., and GRAHAM, F.L. (1994). Construction and propagation of human adenovirus vectors. In Cell Biology: A Laboratory Handbook. J.E. Cells, ed. (Academic Press, San Diego, CA) pp. 479-490.
19. HITT, M., BETT, A.J., ADDISON, C.L., PREVEC, L., and GRAHAM, F.L. (1995). Techniques for human adenovirus vector construction and characterization. In Methods in Molecular Genetics. K.W. Adolph, ed. (Academic Press, Orlando, FL) pp, 13-30.
20. HU, D.E., HORI, Y., and FAN, T.P. (1993). Interleukin-8 stimulates angiogenesis in rats. Inflammation 17, 135-143.
21. KANEGANE, C., SGADARI, C., KANEGANE, H., TERUYA-FELDSTEIN, J., YAO, L., GUPTA, G., FARBER, J.M., LIAO, F., LIU, L., and TOSATO, G. (1998). Contribution of the CXC chemokines IP-10 and Mig to the antitumor effects of IL-12. J. Leukocyte Biol. 64, 384-392.
22. KOCH, A.E., POLVERINI, P.J., KUNKEL, S.L., HARLOW, L.A., DIPIETRO, L.A., ELNER, V.M., ELNER, S.G., and STRIETER, R.M. (1992). Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258, 1798-1801. [See comments].
23. LEE, H.H., and FARBER, J.M. (1996). Localization of the gene for the human MIG cytokine on chromosome 4q21 adjacent to INP10 reveals a chemokine "mini-cluster." Cytogenet. Cell Genet. 74, 255-258.
24. LIAO, F., RABIN, R.L., YANNELLI, J.R., KONIARIS, L.G., VANGURI, P., and FARBER, J.M. (1995). Human Mig chemokine: Biochemical and functional characterization. J. Exp. Med. 182, 1301-1314.
25. LOETSCHER, M., GERBER, B., LOETSCHER, P., JONES, S.A., PIALI, L., CLARK-LEWIS, I., BAGGIOLINI, M., and MOSER, B. (1996). Chemokine receptor specific for IP10 and mig: Structure, function, and expression in activated T-lymphocytes. J. Exp. Med. 184, 963-969. [See comments].
26. LUSTER, A.D., UNKELESS, J.C., and RAVETCH, J.V. (1985). Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature (London) 315, 672-676.
27. MAIONE, T.E., GRAY, G.S., PETRO, J., HUNT, A.J., DONNER, A.L., BAUER, S.I., CARSON, H.F., and SHARPE, R.J. (1990). Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 247, 77-79.
28. MINNA, J.D. (1991). Neoplasma of the lung. In Principles of Internal Medicine. K.J. Isselbacher, ed. (McGraw-Hill, New York) pp. 1102-1110.
29. O'REILLY, M.S., HOLMGREN, L., SHING, Y., CHEN, C., ROSENTHAL, R.A., MOSES, M., LANE, W.S., CAO, Y., SAGE, E.H., and FOLKMAN, J. (1994). Angiostatin: A novel angiogenesis inhibitor that mediates suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328.
30. O'REILLY, M.S., BOEHM, T., SHING, Y., FUKAI, N., VASIOS, G., LANE, W.S., FLYNN, E., BIRKHEAD, J.R., OLSEN, B.R., and FOLKMAN, J. (1997). Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277-285.
31. SARRIS, A.H., BROXMEYER, H.E., WIRTHMUELLER, U., KARASAVVAS, N., COOPER, S., LU, L., KRUEGER, J., and RAVETCH, J.V. (1993). Human interferon-inducible protein 10: Expression and purification of recombinant protein demonstrate inhibition of early human hematopoietic progenitors. J. Exp. Med. 178, 1127-1132.
32. SCHWARTZ, G.N., LIAO, F., GRESS, R.E., and FARBER, J.M. (1997). Suppressive effects of recombinant human monokine induced by IFN-gamma (rHuMig) chemokine on the number of committed and primitive hemopoietic progenitors in liquid cultures of CD34+ human bone marrow cells. J. Immunol. 159, 895-904.
33. SGADARI, C., FARBER, J.M., ANGIOLILLO, A.L., LIAO, F., TERUYA-FELDSTEIN, J., BURD, P.R., YAO, L., GUPTA, G., KANEGANE, C., and TOSATO, G. (1997). Mig, the monokine induced by interferon-gamma, promotes tumor necrosis in vivo. Blood 89, 2635-2643.
34. SOTO, H., WANG, W., STREITER, R.M., COPELAND, N.G., GILBERT, D.J., JENKINS, N.A., HEDRICK, J., and ZLOTNIK, A. (1998). The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3. Proc. Natl. Acad. Sci. U.S.A. 95, 8205-8210.
35. STANDIFORD, T.J., KUNKEL, S.L., BASHA, M.A., CHENSUE, S.W., LYNCH, J.P.D., TOEWS, G.B., WESTWICK, J., and STRIETER, R.M. (1990). Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung. J. Clin. Invest. 86, 1945-1953.
36. STRIETER, R.M., KUNKEL, S.L., BURDICK, M.D., LINCOLN, P.M., and WALZ, A. (1992). The detection of a novel neutrophil-activating peptide (ENA-78) using a sensitive ELISA. Immunol. Invest. 21, 589-596.
37. STRIETER, R.M., POLVERINI, P.J., KUNKEL, S.L., ARENBERG, D.A., BURDICK, M.D., KASPER, J., DZUIBA, J., VAN DAMME, J., WALZ, A., MARRIOTT, D., CHAN, S.-Y., ROCZNIAK, S., and SHANAFELT, A.B. (1995). The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem. 270, 27348-27357.
38. TANAKA, T., MANOME, Y., WEN, P., KUFE, D.W., and FINE, H.A. (1997). Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth. Nature Med. 3, 437-442.
39. TANAKA, T., CAO, Y., FOLKMAN, J., and FINE, H.A. (1998). Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatic complementary DNA. Cancer Res. 58, 3362-3369.
40. TANNENBAUM, C.S., TUBBS, R., ARMSTRONG, D., FINKE, J.H., BUKOWSKI, R.M., and HAMILTON, T.A. (1998). The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor. J. Immunol. 161, 927-932.
41. TAUB, D.D., LLOYD, A.R., CONLON, K., WANG, J.M., ORTALDO, J.R., HARADA, A., MATSUSHIMA, K., KELVIN, D.J., and OPPENHEIM, J.J. (1993). Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J. Exp. Med. 177, 1809-1814.
42. TAUB, D.D., SAYERS, T.J., CARTER, C.R., and ORTALDO, J.R. (1995). Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. J. Immunol. 155, 3877-3888.
43. WEIDNER, N. (1995). Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res. Treat. 36, 169-180.
44. WEIDNER, N., CARROLL, P.R., FLAX, J., BLUMENFELD, W., and FOLKMAN, J. (1993). Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am. J. Pathol. 143, 401-409.
45. WU, Z., O'REILLY, M.S., FOLKMAN, J., and SHING, Y. (1997). Suppression of tumor growth with recombinant murine angiostatin. Biochem. Biophys. Res. Commun. 236, 651-654.